Canada markets open in 1 hour 24 minutes

China Regenerative Medicine International Limited (8158.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
0.185+0.003 (+1.65%)
At close: 03:18PM HKT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
180,525
231,612
282,897
182,136
Cost of Revenue
134,275
193,989
215,170
140,328
Gross Profit
46,250
37,623
67,727
41,808
Operating Expenses
Selling General and Administrative
39,749
25,817
47,446
46,948
Total Operating Expenses
46,998
32,608
50,047
79,337
Operating Income or Loss
-748
5,015
17,680
-37,529
Interest Expense
1,078
781
736
18,524
Income Before Tax
-1,262
8,267
64,292
-142,099
Income Tax Expense
-1,939
3,712
12,465
12,380
Income from Continuing Operations
677
4,555
51,827
-154,479
Net Income
677
4,555
13,348
-404,226
Net Income available to common shareholders
677
4,555
13,348
-404,226
Basic EPS
0.01
0.02
0.10
-2.80
Diluted EPS
0.01
0.02
0.10
-2.80
Basic Average Shares
285,429
285,429
285,429
160,677
Diluted Average Shares
285,429
285,429
285,429
160,677